Nicholas E. Connor

Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study

Samir K. Saha, Stephanie J. Schrag, Shams El Arifeen et al. · The Lancet · 2018 · 221 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial

Deborah Watson‐Jones, John Changalucha, Hilary Whitworth et al. · The Lancet Global Health · 2022 · 113 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Infection Surveillance Protocol for a Multicountry Population-based Study in South Asia to Determine the Incidence, Etiology and Risk Factors for Infections Among Young Infants of 0 to 59 Days Old

Mohammad Shahidul Islam, Abdullah H Baqui, Anita K. M. Zaidi et al. · The Pediatric Infectious Disease Journal · 2016 · 32 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

Daniela Manno, Agnes Bangura, Frank Baiden et al. · The Lancet Infectious Diseases · 2022 · 25 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17